Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers ...

The proposal should be withdrawn. It is untethered to the Inflation Reduction Act and science and undercuts the incentive to ...

ALEXANDRIA, VA / ACCESS Newswire / June 13, 2025 / The American Society of Consultant Pharmacists (ASCP) and the National Community Pharmacists Association (NCPA) have announced joint recommendations ...

Launch prices for anticancer drugs covered under Medicare Part D continue to rise, even with recent Inflation Reduction Act ...

This could force many local pharmacies to choose between stocking critical medications or keeping their doors open.

Key pharma reforms are up in the air as Republicans battle over their mammoth legislation that includes significant ...

President Donald Trump’s proposal to peg American drug costs to prices paid in other countries risks upending Medicaid’s drug ...

Witnesses at the April 8 hearing told legislators biosimilars save patients and taxpayers money, that pharmacy benefit ...

Mark Cuban has supported Rep. Ro Khanna's 'Progressive Deficit Reduction Plan,' which aims to slash the U.S. deficit by $12 ...

The president promised lower prices on medications for Americans, but the state’s independent pharmacies doubt that will ...

Pursuing the worthy goal of reforming drug pricing requires a more radical change to the pharmaceutical industry.